Approval · Notice of Compliance 3209 · 1998
ZOLOFT: Notice of Compliance 3209
Issued April 6, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3209
- Date
- April 6, 1998
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Provides for new indication: treatment of obsessive compulsive disorder
- Therapeutic class
- Antidepressant/antipanic/antiobsessional agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZOLOFT | Not yet assigned | — |
Medicinal ingredients
- SERTRALINE HYDROCHLORIDE 50 MG per CAP
- SERTRALINE HYDROCHLORIDE 100 MG per CAP
- SERTRALINE HYDROCHLORIDE 150 MG per CAP
- SERTRALINE HYDROCHLORIDE 200 MG per CAP